T1	Participants 793 917	European Organization for Research and Treatment of Cancer (n = 946) and the other by the Southwest Oncology Group (n = 746)
T2	Participants 39 128	the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors
